Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland

Health Policy

Volumn 82, Issue 3, 2007, Pages 366-374

  Heikkilä, Reeta ^a   Mäntyselkä, Pekka ^a,b   Hartikainen Herranen, Kaisa ^a   Ahonen, Riitta ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Customers; Experiences; Generic substitution; Opinions; Physicians

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GENERIC DRUG; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST CONTROL; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; FEMALE; FINLAND; GENERAL PRACTITIONER; GEOGRAPHIC DISTRIBUTION; GERIATRICS; HEALTH CARE COST; HUMAN; INTERNAL MEDICINE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MEDICINE; PATIENT; PERSONAL EXPERIENCE; PHARMACIST; PHARMACY; PHYSICIAN; PSYCHIATRIST; PUBLIC OPINION; QUESTIONNAIRE;

ATTITUDE OF HEALTH PERSONNEL; CONSUMER SATISFACTION; DRUGS, GENERIC; FEMALE; FINLAND; GEORGIA; HUMANS; INTERVIEWS; LEGISLATION, DRUG; MALE; MIDDLE AGED; PHYSICIANS; PRESCRIPTIONS, DRUG; QUESTIONNAIRES;

EID: 34250731184     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2006.10.006     Document Type: Article

References (21)

1. Lääkekorvaustyöryhmä 2000:n loppuraportti. Helsinki: Ministry of Social Affairs and Health; 2001.
2. The Social Insurance Institution of Finland a. Lääkekorvaukset ja -kustannukset vuosina 1993-2003. Retrieved 10.10.2005 from http://193.209.217.5/in/internet/suomi/suomi.nsf/NET/010802100436PB
3. Martikainen J., and Rajaniemi S. Drug reimbursement systems in EU Member States, Iceland and Norway (2002), The Social Insurance Institution of Finland, Helsinki
4. Martikainen J., Rajaniemi S., and Klaukka T. Lääkekorvaukset 1990-luvulla (1999), The Social Insurance Institution of Finland, Helsinki
5. The Social Insurance Institution of Finland b. Lääkevaihdon ensimmäinen vuosi. Retrieved 10.10.2005 from http://193.209.217.5/in/internet/suomi.nsf/NET/170504133949MP?OpenDocument.
6. Finnish Statistics on Medicines 2003. Helsinki: National Agency for Medicines and The Social Insurance Institution of Finland; 2004.
7. National Agency for Medicines. Criteria used in compiling the list. Retrieved 10.10.2005 from http://www.nam.fi/english/medicines/substitutable_medicinal_products/criteria_used/index.html
8. Klaukka T., and Kostiainen E. Lääkevaihto on laskenut hintoja enimmillään yli 80%. Suomen Lääkärilehti 59 (2004) 2148-2150
9. Statistics Finland. Lääkkeiden tukkuhinnat laskivat 1.8 prosenttia vuonna 2003. Helsinki; 2004.
10. Wolfgang A.P., and Perri M. Older adults and generic drugs: analysis of attitudes and intentions. Journal of Pharmaceutical Marketing Management 5 (1991) 97-106
11. Andersen M.L., Laursen K., Schaumann M., Rubak S.L., Olesgaard P., Mainz J., et al. Hvordan vurderer patienterne lægemiddelsubstitutionsordningen?. Ugeskr Laeger 162 (2000) 6066-6069
12. Socialstyrelsen. Patientsäkerhet vid utbyte av läkemedel på apotek. Retrieved 10.10.2005 from http://www.socialstyrelsen.se/Publicerat/2004/8557/2004-103-14.htm
13. Tilyard M.W., Dovey S.M., and Rosenstreich D. General practitioners' views on generic medication and substitution. New Zealand Medical Journal 103 (1990) 318-320
14. Rubak S.L., Andersen M.L., Mainz J., Olesgaard P., and Lauritzen T. Hvordan vurderer praktiserende læger lægemiddelsubstitutionsordningen?. Ugeskr Laeger 162 (2000) 6070-6073
15. Banahan B.F., and Kolassa E.M. A physician survey on generic drugs and substitution of critical dose medications. Archives of Internal Medicine 157 (1997) 2080-2088
16. Brust M., Hawkins C.F., and Grayson D. Physicians' attitudes toward generic drug substitution by pharmacists. Texas Medicine 86 (1990) 45-49
17. Banahan B.F., Bonnarens J.K., and Bentley J.P. Generic substitution of NTI drugs: issues for formulary committee consideration. Formulary 33 (1998) 1082-1096
18. Andersson K., Jörgensen T., and Carlsten A. Physicians' opinions and experiences of the Pharmaceutical Benefits Reform. Scandinavian Journal of Public Health (2006) [Published Online 1.6.2006]
19. Mott D.A., and Cline R.R. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Medical Care 40 (2002) 662-674
20. Sihvo S., Ahonen R., Mikander H., and Hemminki E. Self-medication with vaginal antifungal drugs: physicians' experiences and women's utilization patterns. Family Practice 17 (2000) 145-149
21. Sihvo S., and Hemminki E. Self-medication of dyspepsia: how appropriate is it?. Scandinavian Journal of Gastroenterology 32 (1997) 855-861